Kappa Free Light Chain Drift Prompts the Need for a New Upper Limit of Normal Free Light Chain Ratio to Avoid an Epidemic of Kappa Light Chain Monoclonal Gammopathy of Undermined Significance
The Journal of Applied Laboratory Medicine · 2023
DOI: 10.1093/jalm/jfad027 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Applied Laboratory Medicine, 2023. Verfasst von Krasimira Rozenova und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States. Hauptthemen laut MEDLINE: Paraproteinemias, Monoclonal Gammopathy of Undetermined Significance. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
Background
Multiple laboratory tests are employed for detection of monoclonal proteins in patients and include serum protein electrophoresis (SPEP), immunofixation electrophoresis, free light chain (FLC) immunoassay, and mass spectrometry (Mass-Fix). Recently, reports on a drift in FLC quantitation results have been brought to light.
Methods
We studied a cohort of 16 887 patients whose sera were tested for a monoclonal protein by a FLC assay, serum protein electrophoresis, and Mass-Fix. This is a retrospective study designed to assess the impact of a drift on the performance of FLC ratio (rFLC) in groups of patients with and without detectable plasma cell disorders (PCDs).
Results
The results demonstrated that 63% of patients with monoclonal protein equal or higher than 2 g/L (by SPEP) had an abnormal rFLC (reference range 0.26–1.65). Conversely, 16% of patients with undetectable monoclonal protein by other methods (i.e., SPEP and Mass-Fix) who also had no record of treated PCD had an abnormal rFLC. In these cases, there was an imbalance in the number of kappa high rFLCs to lambda low rFLCs of 201 to 1.
Conclusions
The results of this study suggest decreased specificity of rFLC for a monoclonal kappa FLC in the 1.65 to 3.0 range.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States.
- Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, United States.
- Division of Hematology, Mayo Clinic, Rochester, MN, United States.
ORCID-Profile: Krasimira Rozenova, Maria Willrich, David L Murray
Zitieren
APA
Rozenova, K., Willrich, M., Snyder, M., Dasari, S., Kourelis, T., Rajkumar, S. V., Kumar, S., Dispenzieri, A., & Murray, D. L. (2023). Kappa Free Light Chain Drift Prompts the Need for a New Upper Limit of Normal Free Light Chain Ratio to Avoid an Epidemic of Kappa Light Chain Monoclonal Gammopathy of Undermined Significance. The Journal of Applied Laboratory Medicine. https://doi.org/10.1093/jalm/jfad027
Vancouver
Rozenova K, Willrich M, Snyder M, Dasari S, Kourelis T, Rajkumar SV, et al. Kappa Free Light Chain Drift Prompts the Need for a New Upper Limit of Normal Free Light Chain Ratio to Avoid an Epidemic of Kappa Light Chain Monoclonal Gammopathy of Undermined Significance. The Journal of Applied Laboratory Medicine. 2023. doi:10.1093/jalm/jfad027
BibTeX
@article{Rozenova2023,
author = {Rozenova, Krasimira and Willrich, Maria and Snyder, Melissa and Dasari, Surendra and Kourelis, Taxiarchis and Rajkumar, S Vincent and Kumar, Shaji and Dispenzieri, Angela and Murray, David L},
title = {Kappa Free Light Chain Drift Prompts the Need for a New Upper Limit of Normal Free Light Chain Ratio to Avoid an Epidemic of Kappa Light Chain Monoclonal Gammopathy of Undermined Significance},
journal = {The Journal of Applied Laboratory Medicine},
year = {2023},
doi = {10.1093/jalm/jfad027}
}
EUVIMED